Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Heliospectra AB is a leading innovator in the agricultural technology sector, specializing in smart lighting solutions for commercial greenhouses and controlled plant growth environments. The company designs and manufactures adjustable LED lighting systems that offer dynamic control over light intensity, timing, and spectrum to enhance plant production and quality. Heliospectra's solutions are tailored for a variety of crops, significantly impacting sectors such as horticulture, food production, and medicinal plant cultivation. Through its advanced technology, Heliospectra supports sustainable farming practices by optimizing energy use and increasing yield efficiency. Founded in 2006 and headquartered in Gothenburg, Sweden, Heliospectra is at the forefront of integrating data analytics with horticultural lighting. By leveraging Internet of Things (IoT) technology, they enable growers to monitor and adjust lighting conditions in real-time, ensuring optimal growth cycles. Heliospectra's market role extends beyond just lighting to being a key player in the push for precision agriculture, aiding in the transition towards more resource-efficient and environmentally-conscious farming methods. The company's innovative approach makes it a vital contributor to the evolving landscape of sustainable agriculture and food security on a global scale.
kr 0.00
+kr 0.00 (+0.00%)
Live · 08:59 PM · Twelve Data
The business is unprofitable at the operating level (-145.03% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 12.2% YoY. Margins deteriorated 76.1pp alongside, both lines moving the wrong way.
ROIC dropped from -180.58% to -216.03%, capital efficiency is deteriorating. Negative free cash flow of -kr 33M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
kr 28M
▼ -12.2% YoY
Net Income (TTM)
-kr 43M
▼ -81.7% YoY
Op. Margin
-145.03%
▼ -76.1pp YoY
ROIC
-216.03%
▼ -35.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-kr 33M
▼ -22.7% YoY
Op. Cash Flow (TTM)
-kr 33M
▼ -22.7% YoY
Net Debt
-kr 27M
Net Cash Position
Cash & Equiv.
kr 27M
3Y CAGR: +3.4%
Continue Research
Heliospectra AB (HELIO.XSTO)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Heliospectra AB scores 18/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Heliospectra AB scores 18 out of 100 on Intrinsiqq's quality score, passing 1 of 6 checks, which makes it a lower-quality business on these measures. Recent fundamentals include a -145.0% operating margin and a -216.0% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full check-by-check breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh HELIO.XSTO's valuation and scores 18/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.